HEADER TRANSFERASE 28-NOV-24 9KRO TITLE CRYSTAL STRUCTURE OF SHMT FROM E. FAECIUM WITH MANGIFERIN COMPND MOL_ID: 1; COMPND 2 MOLECULE: SERINE HYDROXYMETHYLTRANSFERASE; COMPND 3 CHAIN: A, B; COMPND 4 SYNONYM: SHMT,SERINE METHYLASE; COMPND 5 EC: 2.1.2.1; COMPND 6 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: ENTEROCOCCUS FAECIUM; SOURCE 3 ORGANISM_TAXID: 1352; SOURCE 4 GENE: GLYA, GLYA_1, B1P95_02920, BU183_09275, BU187_13395, SOURCE 5 BU190_13075, BU192_03790, BXT96_08900, CQR37_06830, CUM68_02790, SOURCE 6 CUN04_11625, CUS10_03200, CWC53_10155, DKP91_07450, DTPHA_1400422, SOURCE 7 DTPHA_600996, EB12_01905, EFMAA708_21800, F6440_11360, GBM44_11330, SOURCE 8 GBM73_12625, GJ652_13105, SAMEA3893517_00378; SOURCE 9 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 10 EXPRESSION_SYSTEM_TAXID: 562 KEYWDS MANGIFERIN, XANTHONE GLYCOSIDE, 1C-METHABOLISM, FOLATE, TRANSFERASE EXPDTA X-RAY DIFFRACTION AUTHOR K.MURAYAMA,H.HAYASHI REVDAT 1 19-MAR-25 9KRO 0 JRNL AUTH H.HAYASHI,K.HASEGAWA,E.SAIJO,E.N.KODAMA,K.MURAYAMA JRNL TITL BINDING OF A POTENTIAL ANTIBACTERIAL DRUG, MANGIFERIN, TO JRNL TITL 2 SERINE HYDROXYMETHYLTRANSFERASE FROM ENTEROCOCCUS FAECIUM. JRNL REF BIOCHEM.BIOPHYS.RES.COMMUN. V. 743 51177 2025 JRNL REFN ESSN 1090-2104 JRNL PMID 39693942 JRNL DOI 10.1016/J.BBRC.2024.151177 REMARK 2 REMARK 2 RESOLUTION. 2.25 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX 1.13_2998 REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : GEOSTD + MONOMER LIBRARY REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.25 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 48.07 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 1.340 REMARK 3 COMPLETENESS FOR RANGE (%) : 100.0 REMARK 3 NUMBER OF REFLECTIONS : 56163 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.177 REMARK 3 R VALUE (WORKING SET) : 0.176 REMARK 3 FREE R VALUE : 0.215 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 3.560 REMARK 3 FREE R VALUE TEST SET COUNT : 2000 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 48.0700 - 5.4200 1.00 4153 154 0.1605 0.1825 REMARK 3 2 5.4200 - 4.3000 1.00 3950 145 0.1548 0.1919 REMARK 3 3 4.3000 - 3.7600 1.00 3918 145 0.1512 0.1867 REMARK 3 4 3.7600 - 3.4200 1.00 3882 144 0.1704 0.2164 REMARK 3 5 3.4200 - 3.1700 1.00 3866 142 0.1822 0.2297 REMARK 3 6 3.1700 - 2.9800 1.00 3852 142 0.1850 0.2474 REMARK 3 7 2.9800 - 2.8300 1.00 3829 142 0.1815 0.2194 REMARK 3 8 2.8300 - 2.7100 1.00 3837 141 0.1887 0.2422 REMARK 3 9 2.7100 - 2.6100 1.00 3832 142 0.1997 0.2259 REMARK 3 10 2.6100 - 2.5200 1.00 3821 141 0.2148 0.3024 REMARK 3 11 2.5200 - 2.4400 1.00 3788 140 0.2233 0.2602 REMARK 3 12 2.4400 - 2.3700 1.00 3817 141 0.2395 0.2998 REMARK 3 13 2.3700 - 2.3100 1.00 3814 141 0.2491 0.2937 REMARK 3 14 2.3100 - 2.2500 1.00 3804 140 0.2703 0.3171 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : FLAT BULK SOLVENT MODEL REMARK 3 SOLVENT RADIUS : 1.11 REMARK 3 SHRINKAGE RADIUS : 0.90 REMARK 3 K_SOL : NULL REMARK 3 B_SOL : NULL REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.260 REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 21.956 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 48.71 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 51.86 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : 0.008 6483 REMARK 3 ANGLE : 0.969 8808 REMARK 3 CHIRALITY : 0.051 1002 REMARK 3 PLANARITY : 0.005 1137 REMARK 3 DIHEDRAL : 3.703 3836 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 9KRO COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBJ ON 03-DEC-24. REMARK 100 THE DEPOSITION ID IS D_1300054161. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 19-APR-24 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : NULL REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : SPRING-8 REMARK 200 BEAMLINE : BL41XU REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.0 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : DECTRIS EIGER X 16M REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : XDS REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 56242 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.250 REMARK 200 RESOLUTION RANGE LOW (A) : 48.100 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 100.0 REMARK 200 DATA REDUNDANCY : 13.40 REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : NULL REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : 17.9000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.25 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.33 REMARK 200 COMPLETENESS FOR SHELL (%) : NULL REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 <I/SIGMA(I)> FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHENIX REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 61.65 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 3.21 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 0.01M MAGNESIUM CHLORIDE, 0.05M MES REMARK 280 (PH5.8), 1.9M LITHIUM SULFATE, 2MM MANGIFERIN, VAPOR DIFFUSION, REMARK 280 HANGING DROP, TEMPERATURE 293K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 41 21 2 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,-Y,Z+1/2 REMARK 290 3555 -Y+1/2,X+1/2,Z+1/4 REMARK 290 4555 Y+1/2,-X+1/2,Z+3/4 REMARK 290 5555 -X+1/2,Y+1/2,-Z+1/4 REMARK 290 6555 X+1/2,-Y+1/2,-Z+3/4 REMARK 290 7555 Y,X,-Z REMARK 290 8555 -Y,-X,-Z+1/2 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 81.80000 REMARK 290 SMTRY1 3 0.000000 -1.000000 0.000000 59.41000 REMARK 290 SMTRY2 3 1.000000 0.000000 0.000000 59.41000 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 40.90000 REMARK 290 SMTRY1 4 0.000000 1.000000 0.000000 59.41000 REMARK 290 SMTRY2 4 -1.000000 0.000000 0.000000 59.41000 REMARK 290 SMTRY3 4 0.000000 0.000000 1.000000 122.70000 REMARK 290 SMTRY1 5 -1.000000 0.000000 0.000000 59.41000 REMARK 290 SMTRY2 5 0.000000 1.000000 0.000000 59.41000 REMARK 290 SMTRY3 5 0.000000 0.000000 -1.000000 40.90000 REMARK 290 SMTRY1 6 1.000000 0.000000 0.000000 59.41000 REMARK 290 SMTRY2 6 0.000000 -1.000000 0.000000 59.41000 REMARK 290 SMTRY3 6 0.000000 0.000000 -1.000000 122.70000 REMARK 290 SMTRY1 7 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY2 7 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY3 7 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 8 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY2 8 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY3 8 0.000000 0.000000 -1.000000 81.80000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 7340 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 27620 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -42.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLY A -2 REMARK 465 PRO A -1 REMARK 465 GLY A 0 REMARK 465 VAL A 1 REMARK 465 LYS A 413 REMARK 465 LYS A 414 REMARK 465 GLY B -2 REMARK 465 PRO B -1 REMARK 465 GLY B 0 REMARK 465 VAL B 1 REMARK 465 VAL B 2 REMARK 465 LYS B 413 REMARK 465 LYS B 414 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 OG SER A 172 O3 HZI A 502 2.17 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 HIS A 58 54.11 -142.13 REMARK 500 ALA A 173 43.54 -145.84 REMARK 500 LYS A 226 -108.78 -99.12 REMARK 500 SER A 307 -1.58 76.92 REMARK 500 ASN A 312 -140.03 -136.74 REMARK 500 THR A 355 169.79 60.71 REMARK 500 LYS A 389 69.44 -66.15 REMARK 500 LEU A 411 31.99 -98.35 REMARK 500 ALA B 52 40.36 -146.48 REMARK 500 ALA B 173 38.43 -145.16 REMARK 500 LYS B 226 -103.18 -100.74 REMARK 500 SER B 307 -8.72 73.17 REMARK 500 ASN B 312 -133.72 -129.83 REMARK 500 VAL B 340 -166.51 -124.59 REMARK 500 THR B 355 166.07 55.20 REMARK 500 ALA B 388 75.25 -60.72 REMARK 500 LYS B 389 98.57 -56.51 REMARK 500 LEU B 411 -61.30 -100.04 REMARK 500 REMARK 500 REMARK: NULL DBREF1 9KRO A 2 414 UNP A0A133CK16_ENTFC DBREF2 9KRO A A0A133CK16 2 414 DBREF1 9KRO B 2 414 UNP A0A133CK16_ENTFC DBREF2 9KRO B A0A133CK16 2 414 SEQADV 9KRO GLY A -2 UNP A0A133CK1 EXPRESSION TAG SEQADV 9KRO PRO A -1 UNP A0A133CK1 EXPRESSION TAG SEQADV 9KRO GLY A 0 UNP A0A133CK1 EXPRESSION TAG SEQADV 9KRO VAL A 1 UNP A0A133CK1 EXPRESSION TAG SEQADV 9KRO GLY B -2 UNP A0A133CK1 EXPRESSION TAG SEQADV 9KRO PRO B -1 UNP A0A133CK1 EXPRESSION TAG SEQADV 9KRO GLY B 0 UNP A0A133CK1 EXPRESSION TAG SEQADV 9KRO VAL B 1 UNP A0A133CK1 EXPRESSION TAG SEQRES 1 A 417 GLY PRO GLY VAL VAL ASP TYR LYS THR PHE ASP PRO ASP SEQRES 2 A 417 LEU TRP ALA ALA ILE ALA LYS GLU GLU GLU ARG GLN GLU SEQRES 3 A 417 HIS ASN LEU GLU LEU ILE ALA SER GLU ASN PHE VAL SER SEQRES 4 A 417 GLU ALA VAL MET ALA ALA GLN GLY SER ILE LEU THR ASN SEQRES 5 A 417 LYS TYR ALA GLU GLY TYR PRO GLY HIS ARG TYR TYR GLY SEQRES 6 A 417 GLY CYS GLU PHE VAL ASP ILE VAL GLU ASN LEU ALA ILE SEQRES 7 A 417 ASP ARG ALA LYS GLU LEU PHE GLY ALA LYS PHE ALA ASN SEQRES 8 A 417 VAL GLN PRO HIS SER GLY SER GLN ALA ASN THR ALA ALA SEQRES 9 A 417 TYR LEU ALA LEU VAL GLU PRO GLY ASP THR ILE LEU GLY SEQRES 10 A 417 MET ASP LEU SER ALA GLY GLY HIS LEU THR HIS GLY SER SEQRES 11 A 417 PRO VAL ASN PHE SER GLY LYS THR TYR HIS PHE VAL ALA SEQRES 12 A 417 TYR GLY VAL ASP PRO THR THR GLU VAL ILE ASP TYR ASN SEQRES 13 A 417 VAL VAL ARG ILE LEU ALA ARG LYS HIS GLN PRO LYS LEU SEQRES 14 A 417 ILE VAL ALA GLY ALA SER ALA TYR GLY ARG THR ILE ASP SEQRES 15 A 417 PHE ALA LYS PHE ARG GLU ILE ALA ASP GLU VAL GLY ALA SEQRES 16 A 417 LYS LEU MET VAL ASP MET ALA HIS ILE ALA GLY LEU VAL SEQRES 17 A 417 ALA ALA GLY LEU HIS PRO ASN PRO VAL PRO TYR ALA ASP SEQRES 18 A 417 ILE THR THR THR THR THR HIS LYS THR LEU ARG GLY PRO SEQRES 19 A 417 ARG GLY GLY MET ILE LEU THR ASN ASP GLU ALA LEU ALA SEQRES 20 A 417 LYS LYS ILE ASN SER ALA VAL PHE PRO GLY ILE GLN GLY SEQRES 21 A 417 GLY PRO LEU GLU HIS VAL ILE ALA GLY LYS ALA VAL ALA SEQRES 22 A 417 PHE LYS GLU ALA LEU ASP PRO ALA PHE LYS GLU TYR SER SEQRES 23 A 417 GLU GLN ILE ILE ALA ASN ALA LYS ALA MET VAL LYS VAL SEQRES 24 A 417 PHE ASN GLN ALA ILE GLY THR ARG VAL ILE SER GLY ALA SEQRES 25 A 417 THR ASP ASN HIS LEU MET LEU ILE ASP VAL ARG GLU LEU SEQRES 26 A 417 GLY ILE ASN GLY LYS GLU ALA GLU SER ILE LEU ASP SER SEQRES 27 A 417 VAL ASN ILE THR VAL ASN LYS ASN SER ILE PRO PHE GLU SEQRES 28 A 417 THR LEU SER PRO PHE LYS THR SER GLY ILE ARG ILE GLY SEQRES 29 A 417 THR PRO ALA ILE THR THR ARG GLY PHE LYS GLU GLU ASP SEQRES 30 A 417 ALA VAL LYS VAL ALA GLU LEU VAL VAL LYS ALA LEU GLN SEQRES 31 A 417 ALA LYS ASP ASP ASN ALA GLN LEU ASP GLU VAL LYS THR SEQRES 32 A 417 GLY VAL ARG GLU LEU THR GLU LYS PHE PRO LEU HIS LYS SEQRES 33 A 417 LYS SEQRES 1 B 417 GLY PRO GLY VAL VAL ASP TYR LYS THR PHE ASP PRO ASP SEQRES 2 B 417 LEU TRP ALA ALA ILE ALA LYS GLU GLU GLU ARG GLN GLU SEQRES 3 B 417 HIS ASN LEU GLU LEU ILE ALA SER GLU ASN PHE VAL SER SEQRES 4 B 417 GLU ALA VAL MET ALA ALA GLN GLY SER ILE LEU THR ASN SEQRES 5 B 417 LYS TYR ALA GLU GLY TYR PRO GLY HIS ARG TYR TYR GLY SEQRES 6 B 417 GLY CYS GLU PHE VAL ASP ILE VAL GLU ASN LEU ALA ILE SEQRES 7 B 417 ASP ARG ALA LYS GLU LEU PHE GLY ALA LYS PHE ALA ASN SEQRES 8 B 417 VAL GLN PRO HIS SER GLY SER GLN ALA ASN THR ALA ALA SEQRES 9 B 417 TYR LEU ALA LEU VAL GLU PRO GLY ASP THR ILE LEU GLY SEQRES 10 B 417 MET ASP LEU SER ALA GLY GLY HIS LEU THR HIS GLY SER SEQRES 11 B 417 PRO VAL ASN PHE SER GLY LYS THR TYR HIS PHE VAL ALA SEQRES 12 B 417 TYR GLY VAL ASP PRO THR THR GLU VAL ILE ASP TYR ASN SEQRES 13 B 417 VAL VAL ARG ILE LEU ALA ARG LYS HIS GLN PRO LYS LEU SEQRES 14 B 417 ILE VAL ALA GLY ALA SER ALA TYR GLY ARG THR ILE ASP SEQRES 15 B 417 PHE ALA LYS PHE ARG GLU ILE ALA ASP GLU VAL GLY ALA SEQRES 16 B 417 LYS LEU MET VAL ASP MET ALA HIS ILE ALA GLY LEU VAL SEQRES 17 B 417 ALA ALA GLY LEU HIS PRO ASN PRO VAL PRO TYR ALA ASP SEQRES 18 B 417 ILE THR THR THR THR THR HIS LYS THR LEU ARG GLY PRO SEQRES 19 B 417 ARG GLY GLY MET ILE LEU THR ASN ASP GLU ALA LEU ALA SEQRES 20 B 417 LYS LYS ILE ASN SER ALA VAL PHE PRO GLY ILE GLN GLY SEQRES 21 B 417 GLY PRO LEU GLU HIS VAL ILE ALA GLY LYS ALA VAL ALA SEQRES 22 B 417 PHE LYS GLU ALA LEU ASP PRO ALA PHE LYS GLU TYR SER SEQRES 23 B 417 GLU GLN ILE ILE ALA ASN ALA LYS ALA MET VAL LYS VAL SEQRES 24 B 417 PHE ASN GLN ALA ILE GLY THR ARG VAL ILE SER GLY ALA SEQRES 25 B 417 THR ASP ASN HIS LEU MET LEU ILE ASP VAL ARG GLU LEU SEQRES 26 B 417 GLY ILE ASN GLY LYS GLU ALA GLU SER ILE LEU ASP SER SEQRES 27 B 417 VAL ASN ILE THR VAL ASN LYS ASN SER ILE PRO PHE GLU SEQRES 28 B 417 THR LEU SER PRO PHE LYS THR SER GLY ILE ARG ILE GLY SEQRES 29 B 417 THR PRO ALA ILE THR THR ARG GLY PHE LYS GLU GLU ASP SEQRES 30 B 417 ALA VAL LYS VAL ALA GLU LEU VAL VAL LYS ALA LEU GLN SEQRES 31 B 417 ALA LYS ASP ASP ASN ALA GLN LEU ASP GLU VAL LYS THR SEQRES 32 B 417 GLY VAL ARG GLU LEU THR GLU LYS PHE PRO LEU HIS LYS SEQRES 33 B 417 LYS HET PLS A 501 22 HET HZI A 502 30 HET PLS B 501 22 HET HZI B 502 30 HETNAM PLS [3-HYDROXY-2-METHYL-5-PHOSPHONOOXYMETHYL-PYRIDIN-4- HETNAM 2 PLS YLMETHYL]-SERINE HETNAM HZI MANGIFERIN HETSYN PLS PYRIDOXYL-SERINE-5-MONOPHOSPHATE HETSYN HZI 2-[(2S,3R,4R,5S,6R)-6-(HYDROXYMETHYL)-3,4,5- HETSYN 2 HZI TRIS(OXIDANYL)OXAN-2-YL]-1,3,6,7-TETRAKIS(OXIDANYL) HETSYN 3 HZI XANTHEN-9-ONE FORMUL 3 PLS 2(C11 H17 N2 O8 P) FORMUL 4 HZI 2(C19 H18 O11) FORMUL 7 HOH *199(H2 O) HELIX 1 AA1 VAL A 2 ASP A 8 1 7 HELIX 2 AA2 ASP A 8 ASN A 25 1 18 HELIX 3 AA3 SER A 36 GLY A 44 1 9 HELIX 4 AA4 SER A 45 LYS A 50 5 6 HELIX 5 AA5 CYS A 64 GLY A 83 1 20 HELIX 6 AA6 SER A 93 VAL A 106 1 14 HELIX 7 AA7 LEU A 117 GLY A 120 5 4 HELIX 8 AA8 HIS A 122 GLY A 126 5 5 HELIX 9 AA9 ASN A 130 TYR A 136 1 7 HELIX 10 AB1 ASP A 151 GLN A 163 1 13 HELIX 11 AB2 ASP A 179 GLY A 191 1 13 HELIX 12 AB3 ILE A 201 ALA A 207 1 7 HELIX 13 AB4 ASP A 240 PHE A 252 1 13 HELIX 14 AB5 LEU A 260 ASP A 276 1 17 HELIX 15 AB6 ASP A 276 ALA A 300 1 25 HELIX 16 AB7 ARG A 320 GLY A 323 5 4 HELIX 17 AB8 ASN A 325 VAL A 336 1 12 HELIX 18 AB9 THR A 362 ARG A 368 1 7 HELIX 19 AC1 LYS A 371 ALA A 388 1 18 HELIX 20 AC2 ASP A 391 PHE A 409 1 19 HELIX 21 AC3 ASP B 3 PHE B 7 5 5 HELIX 22 AC4 ASP B 8 ASN B 25 1 18 HELIX 23 AC5 SER B 36 GLY B 44 1 9 HELIX 24 AC6 SER B 45 LYS B 50 5 6 HELIX 25 AC7 PHE B 66 GLY B 83 1 18 HELIX 26 AC8 SER B 93 ALA B 104 1 12 HELIX 27 AC9 LEU B 117 GLY B 120 5 4 HELIX 28 AD1 HIS B 122 GLY B 126 5 5 HELIX 29 AD2 ASN B 130 TYR B 136 1 7 HELIX 30 AD3 ASP B 151 GLN B 163 1 13 HELIX 31 AD4 ASP B 179 GLY B 191 1 13 HELIX 32 AD5 ILE B 201 ALA B 207 1 7 HELIX 33 AD6 ASP B 240 PHE B 252 1 13 HELIX 34 AD7 LEU B 260 ASP B 276 1 17 HELIX 35 AD8 ASP B 276 GLN B 299 1 24 HELIX 36 AD9 ARG B 320 GLY B 323 5 4 HELIX 37 AE1 ASN B 325 VAL B 336 1 12 HELIX 38 AE2 THR B 362 ARG B 368 1 7 HELIX 39 AE3 LYS B 371 ALA B 388 1 18 HELIX 40 AE4 ASP B 391 PHE B 409 1 19 SHEET 1 AA1 2 LEU A 26 GLU A 27 0 SHEET 2 AA1 2 ILE A 338 THR A 339 1 O THR A 339 N LEU A 26 SHEET 1 AA2 2 GLY A 54 TYR A 55 0 SHEET 2 AA2 2 HIS A 58 ARG A 59 -1 O HIS A 58 N TYR A 55 SHEET 1 AA3 7 PHE A 86 ASN A 88 0 SHEET 2 AA3 7 GLY A 234 THR A 238 -1 O ILE A 236 N ASN A 88 SHEET 3 AA3 7 ILE A 219 THR A 223 -1 N THR A 220 O LEU A 237 SHEET 4 AA3 7 LYS A 193 ASP A 197 1 N VAL A 196 O THR A 221 SHEET 5 AA3 7 LEU A 166 ALA A 169 1 N ILE A 167 O MET A 195 SHEET 6 AA3 7 THR A 111 MET A 115 1 N LEU A 113 O VAL A 168 SHEET 7 AA3 7 HIS A 137 TYR A 141 1 O HIS A 137 N ILE A 112 SHEET 1 AA4 4 ARG A 304 VAL A 305 0 SHEET 2 AA4 4 LEU A 314 ASP A 318 -1 O ASP A 318 N ARG A 304 SHEET 3 AA4 4 GLY A 357 GLY A 361 -1 O ILE A 358 N ILE A 317 SHEET 4 AA4 4 ASN A 341 ASN A 343 -1 N ASN A 341 O ARG A 359 SHEET 1 AA5 2 LEU B 26 GLU B 27 0 SHEET 2 AA5 2 ILE B 338 THR B 339 1 O THR B 339 N LEU B 26 SHEET 1 AA6 2 GLY B 54 TYR B 55 0 SHEET 2 AA6 2 HIS B 58 ARG B 59 -1 O HIS B 58 N TYR B 55 SHEET 1 AA7 7 PHE B 86 ASN B 88 0 SHEET 2 AA7 7 GLY B 234 THR B 238 -1 O ILE B 236 N ASN B 88 SHEET 3 AA7 7 ILE B 219 THR B 223 -1 N THR B 220 O LEU B 237 SHEET 4 AA7 7 LYS B 193 ASP B 197 1 N VAL B 196 O THR B 221 SHEET 5 AA7 7 LEU B 166 ALA B 169 1 N ILE B 167 O LYS B 193 SHEET 6 AA7 7 THR B 111 MET B 115 1 N LEU B 113 O VAL B 168 SHEET 7 AA7 7 HIS B 137 TYR B 141 1 O VAL B 139 N ILE B 112 SHEET 1 AA8 4 ARG B 304 VAL B 305 0 SHEET 2 AA8 4 LEU B 314 ASP B 318 -1 O ASP B 318 N ARG B 304 SHEET 3 AA8 4 GLY B 357 GLY B 361 -1 O ILE B 360 N MET B 315 SHEET 4 AA8 4 ASN B 341 ASN B 343 -1 N ASN B 343 O GLY B 357 CISPEP 1 PHE A 252 PRO A 253 0 7.64 CISPEP 2 PHE B 252 PRO B 253 0 7.42 CRYST1 118.820 118.820 163.600 90.00 90.00 90.00 P 41 21 2 16 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.008416 0.000000 0.000000 0.00000 SCALE2 0.000000 0.008416 0.000000 0.00000 SCALE3 0.000000 0.000000 0.006112 0.00000